Cwm, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Cwm, LLC
- $33.3 Billion
- Q3 2025
A detailed history of Cwm, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 29,287 shares of ALNY stock, worth $14 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
29,287
Previous 5,512
431.33%
Holding current value
$14 Million
Previous $1.8 Million
643.18%
% of portfolio
0.04%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding ALNY
# of Institutions
803Shares Held
116MCall Options Held
584KPut Options Held
648K-
Capital World Investors Los Angeles, CA16.8MShares$8.04 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$6.36 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.57 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.44 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.28MShares$2.05 Billion0.88% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $58.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...